| Literature DB >> 28632968 |
Abstract
The topic of precision medicine is increasingly more prevalent in the general medical literature, with oncology research leading the way. Many factors, such as availability of targeted drugs, advances in laboratory science, and improved information systems, converged to make precision medicine research possible on a large scale at the National Cancer Institute. The resultant big data will spur new kinds of research in the decades to come, but until then, all clinicians are challenged to make sense of an overabundance of information when managing individual patients. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.Entities:
Keywords: National Cancer Institute; The Cancer Genome Atlas; molecular tumor board
Mesh:
Year: 2017 PMID: 28632968 PMCID: PMC5669055 DOI: 10.1002/phar.1975
Source DB: PubMed Journal: Pharmacotherapy ISSN: 0277-0008 Impact factor: 4.705